Sara E. Oliver

6.2k citations
55 papers · 3.1k · 3 hit papers · h-index 20

Impact in

  • Health top 0.5%
    • Vaccine Coverage and Hesitancy
  • Infectious Diseases top 1%
    • SARS-CoV-2 and COVID-19 Research
    • COVID-19 Clinical Research Studies

Papers in

  • Infectious Diseases 22
    • SARS-CoV-2 and COVID-19 Research 19
    • Viral gastroenteritis research and epidemiology 4
  • Health 20
    • Vaccine Coverage and Hesitancy 20
Co-authors
Grace M. Lee (16 shared papers)H. Keipp Talbot (15 shared papers)Megan Wallace (17 shared papers)José R. Romero (11 shared papers)Beth P. Bell (14 shared papers)Kathleen Dooling (13 shared papers)Mary E. Chamberland (9 shared papers)Nancy McClung (8 shared papers)
Journals
MMWR Morbidity and Mortality Weekly Report (19 papers)Vaccine (5 papers)Sexually Transmitted Diseases (4 papers)Clinical Infectious Diseases (4 papers)International Journal of Environmental Research and Public Health (1 paper)
Partner nations
United StatesCanadaFrance

In The Last Decade

Sara E. Oliver

55 papers receiving 2.9k citations

Sara E. Oliver's Hit Papers

Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021 2021 · 134 citations
1340+2+4Years since publication100200300400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

  • it has ≥500 total citations;
  • it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
  • it reaches the top citation threshold in at least one of its specific research topics.
  1. 2021 MMWR Morbidity and Mortality Weekly Report
  2. 2021 MMWR Morbidity and Mortality Weekly Report
  3. 2020 MMWR Morbidity and Mortality Weekly Report

Peers

Sara E. Oliver
Comparison fields: 5 of 128
  • Health 808
  • Infectious Diseases 1.2k
  • Modeling and Simulation 275
  • Microbiology 190
  • Obstetrics and Gynecology 202
Replace Tom T. Shimabukuro with:
Tom T. Shimabukuro United States
Bradley K. Ackerson United States
John M. McLaughlin United States
Kathleen Dooling United States
Julianne Gee United States
Jim McMenamin United Kingdom
Hung Fu Tseng United States
Mark A. Katz United States
Tyra Grove Krause Denmark
Lina S. Sy United States
Sara E. Oliver relative to Tom T. Shimabukuro United States Tom T. Shimabukuro's profile →
Citations per field
00.5×1.5×2.2×
Tom T. Shimabukuro · 1×
Citations per year

Countries citing papers authored by Sara E. Oliver

Since Specialization
Citations

This map shows the geographic impact of Sara E. Oliver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara E. Oliver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara E. Oliver more than expected).

Fields of papers citing papers by Sara E. Oliver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara E. Oliver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara E. Oliver. The network helps show where Sara E. Oliver may publish in the future.

Co-authors

The 25 scholars most cited alongside Sara E. Oliver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sara E. Oliver Line = papers co-authored together Sara E. Oliver links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
MMWR Morbidity and Mortality Weekly Report ·Sara E. Oliver, Julia W. Gargano, Mona Marin, Megan Wallace, Kathryn Curran, Mary E. Chamberland, Nancy McClung, Doug Campos‐Outcalt, Rebecca L. Morgan, Sarah Mbaeyi, José R. Romero, H. Keipp Talbot, Grace M. Lee, Beth P. Bell, Kathleen Dooling
Hit paper breakdown →		2020403
2
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
MMWR Morbidity and Mortality Weekly Report ·Julia W. Gargano, Megan Wallace, Stephen C. Hadler, Gayle Langley, John R. Su, Matthew E. Oster, Karen R. Broder, Julianne Gee, Eric Weintraub, Tom T. Shimabukuro, Heather M. Scobie, Danielle Moulia, Lauri E. Markowitz, Melinda Wharton, Veronica V. McNally, José R. Romero, H. Keipp Talbot, Grace M. Lee, Matthew F. Daley, Sara E. Oliver
Hit paper breakdown →		2021383
3
The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine — United States, December 2020
MMWR Morbidity and Mortality Weekly Report ·Kathleen Dooling, Mona Marin, Megan Wallace, Nancy McClung, Mary E. Chamberland, Grace M. Lee, H. Keipp Talbot, José R. Romero, Beth P. Bell, Sara E. Oliver
2020287
4
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020
MMWR Morbidity and Mortality Weekly Report ·Sara E. Oliver, Julia W. Gargano, Mona Marin, Megan Wallace, Kathryn Curran, Mary E. Chamberland, Nancy McClung, Doug Campos‐Outcalt, Rebecca L. Morgan, Sarah Mbaeyi, José R. Romero, H. Keipp Talbot, Grace M. Lee, Beth P. Bell, Kathleen Dooling
2020230
5
The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020
MMWR Morbidity and Mortality Weekly Report ·Kathleen Dooling, Nancy McClung, Mary E. Chamberland, Mona Marin, Megan Wallace, Beth P. Bell, Grace M. Lee, H. Keipp Talbot, José R. Romero, Sara E. Oliver
2020227
6
Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system
Journal of Clinical Virology ·Sara E. Oliver, Gretchen A. Cloud, Pablo J. Sánchez, Gail J. Demmler, Wayne M. Dankner, Mark Shelton, Richard F. Jacobs, Wendy Vaudry, Robert F. Pass, Seng-Jaw Soong, Richard J. Whitley, David W. Kimberlin
2009200
7
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021
MMWR Morbidity and Mortality Weekly Report ·Jessica R. MacNeil, John R. Su, Karen R. Broder, Alice Guh, Julia W. Gargano, Megan Wallace, Stephen C. Hadler, Heather M. Scobie, Amy Blain, Danielle Moulia, Matthew F. Daley, Veronica V. McNally, José R. Romero, H. Keipp Talbot, Grace M. Lee, Beth P. Bell, Sara E. Oliver
Hit paper breakdown →		2021134
8
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021
MMWR Morbidity and Mortality Weekly Report ·Sara E. Oliver, Julia W. Gargano, Heather M. Scobie, Megan Wallace, Stephen C. Hadler, Jessica W. T. Leung, Amy Blain, Nancy McClung, Doug Campos‐Outcalt, Rebecca L. Morgan, Sarah Mbaeyi, Jessica R. MacNeil, José R. Romero, H. Keipp Talbot, Grace M. Lee, Beth P. Bell, Kathleen Dooling
2021119
9
Prevalence of Human Papillomavirus Among Females After Vaccine Introduction—National Health and Nutrition Examination Survey, United States, 2003–2014
The Journal of Infectious Diseases ·Sara E. Oliver, Elizabeth R. Unger, Rayleen M. Lewis, Darius McDaniel, Julia W. Gargano, Martin Steinau, Lauri E. Markowitz
2017119
10
Ocular Syphilis — Eight Jurisdictions, United States, 2014–2015
MMWR Morbidity and Mortality Weekly Report ·Sara E. Oliver, Mark R. Aubin, Leah Atwell, James Matthias, Anna B. Cope, Victoria Mobley, Alexandra Goode, Sydney Minnerly, Juliet Stoltey, Heidi M. Bauer, Robin R. Hennessy, Dawne DiOrio, Robyn Neblett Fanfair, Thomas A. Peterman, Lauri E. Markowitz
2016111
11
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021
MMWR Morbidity and Mortality Weekly Report ·Kate R. Woodworth, Danielle Moulia, Jennifer P. Collins, Stephen C. Hadler, Jefferson M. Jones, Sujan Reddy, Mary E. Chamberland, Doug Campos‐Outcalt, Rebecca L. Morgan, Oliver Brooks, H. Keipp Talbot, Grace M. Lee, Beth P. Bell, Matthew F. Daley, Sarah Mbaeyi, Kathleen Dooling, Sara E. Oliver
2021101
12
The Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020
MMWR Morbidity and Mortality Weekly Report ·Nancy McClung, Mary E. Chamberland, Kathy Kinlaw, Dayna Bowen Matthew, Megan Wallace, Beth P. Bell, Grace M. Lee, H. Keipp Talbot, José R. Romero, Sara E. Oliver, Kathleen Dooling
202098
13
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021
MMWR Morbidity and Mortality Weekly Report ·Megan Wallace, Kate R. Woodworth, Julia W. Gargano, Heather M. Scobie, Amy Blain, Danielle Moulia, Mary E. Chamberland, Nicole Reisman, Stephen C. Hadler, Jessica R. MacNeil, Doug Campos‐Outcalt, Rebecca L. Morgan, Matthew F. Daley, José R. Romero, H. Keipp Talbot, Grace M. Lee, Beth P. Bell, Sara E. Oliver
202194
14
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022
MMWR Morbidity and Mortality Weekly Report ·Hannah G. Rosenblum, Megan J. Wallace, Monica Godfrey, Lauren E. Roper, Elisha Hall, Katherine E. Fleming-Dutra, Ruth Link‐Gelles, Tamara Pilishvili, Jennifer Williams, Danielle Moulia, Oliver Brooks, H. Keipp Talbot, Grace M. Lee, Beth P. Bell, Matthew F. Daley, Sarah Meyer, Sara E. Oliver, Evelyn Twentyman
202289
15
Increasing Human Papillomavirus Vaccine Coverage Among Men Who Have Sex With Men—National HIV Behavioral Surveillance, United States, 2014
JAIDS Journal of Acquired Immune Deficiency Syndromes ·Sara E. Oliver, Brooke Hoots, Gabriela Paz‐Bailey, Lauri E. Markowitz, Elissa Meites, (unknown)
201745
16
Increases in Ocular Syphilis—North Carolina, 2014–2015
Clinical Infectious Diseases ·Sara E. Oliver, Anna B. Cope, Jessica L. Rinsky, Charnetta Williams, (unknown), Stephanie Hawks, Thomas A. Peterman, Lauri E. Markowitz, Aaron T. Fleischauer, Erika Samoff, (unknown), Jason Hall, Victor J. Hough, Andre Ivey, (unknown), Samantha Greene, Dishonda Taylor, Mike Mercurio, Miraida Gipson
201742
17
Molecular Typing of Treponema pallidum in Ocular Syphilis
Sexually Transmitted Diseases ·Sara E. Oliver, Sharon K. Sahi, Lauren C. Tantalo, Charmie Godornes, Robyn Neblett Fanfair, Lauri E. Markowitz, Sheila A. Lukehart, Christina M. Marra
201638
18
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021
MMWR Morbidity and Mortality Weekly Report ·Kathleen Dooling, Julia W. Gargano, Danielle Moulia, Megan Wallace, Hannah G. Rosenblum, Amy Blain, Stephen C. Hadler, Ian D. Plumb, Heidi L. Moline, Jack Gerstein, Jennifer P. Collins, Monica Godfrey, Doug Campos‐Outcalt, Rebecca L. Morgan, Oliver Brooks, H. Keipp Talbot, Grace M. Lee, Matthew F. Daley, Sara E. Oliver
202126
19
Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022
MMWR Morbidity and Mortality Weekly Report ·Evelyn Twentyman, Megan J. Wallace, Lauren E. Roper, Tara C. Anderson, Amy B. Rubis, Katherine E. Fleming-Dutra, Elisha Hall, Joy Hsu, Hannah G. Rosenblum, Monica Godfrey, W. Roodly Archer, Danielle Moulia, Laura L. Daniel, Oliver Brooks, H. Keipp Talbot, Grace M. Lee, Beth P. Bell, Matthew F. Daley, Sarah Meyer, Sara E. Oliver
202221
20
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023
MMWR Morbidity and Mortality Weekly Report ·Danielle Moulia, Megan Wallace, Lauren E. Roper, Monica Godfrey, Hannah G. Rosenblum, Ruth Link‐Gelles, Amadea Britton, Matthew F. Daley, Sarah Meyer, Katherine E. Fleming-Dutra, Sara E. Oliver, Evelyn Twentyman
202321

About Sara E. Oliver

Sara E. Oliver is a scholar working on Infectious Diseases, Health, Epidemiology, Microbiology and General Health Professions, having authored 55 papers that have together received 3.1k indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (20 papers), SARS-CoV-2 and COVID-19 Research (19 papers), Bacterial Infections and Vaccines (10 papers), Pneumonia and Respiratory Infections (5 papers), Virology and Viral Diseases (4 papers), COVID-19 epidemiological studies (4 papers), Viral gastroenteritis research and epidemiology (4 papers) and Syphilis Diagnosis and Treatment (4 papers). The work is most often cited by research in Health (808 citations), Infectious Diseases (1.2k citations), Modeling and Simulation (275 citations), Microbiology (190 citations) and Obstetrics and Gynecology (202 citations). Sara E. Oliver has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Grace M. Lee, H. Keipp Talbot, Megan Wallace, José R. Romero, Beth P. Bell, Kathleen Dooling, Mary E. Chamberland, Nancy McClung, Julia W. Gargano and Mona Marin. Their work appears in journals such as MMWR Morbidity and Mortality Weekly Report, Vaccine, Sexually Transmitted Diseases, Clinical Infectious Diseases and International Journal of Environmental Research and Public Health.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tom T. ShimabukuroBreakdown of academic impact, for papers by Bradley K. AckersonBreakdown of academic impact, for papers by John M. McLaughlinBreakdown of academic impact, for papers by Kathleen DoolingBreakdown of academic impact, for papers by Julianne GeeBreakdown of academic impact, for papers by Jim McMenaminBreakdown of academic impact, for papers by Hung Fu TsengBreakdown of academic impact, for papers by Mark A. KatzBreakdown of academic impact, for papers by Tyra Grove KrauseBreakdown of academic impact, for papers by Lina S. Sy